Maria R. Pellico

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles, and patient-reported outcomes.

Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles, and patient-reported outcomes.

Journal: Rheumatology (Oxford, England)

Published: May 22, 2026

Anifrolumab for rituximab-induced SCLE and cryoglobulinemic vasculitis in primary Sjögren's disease: a case report.

Anifrolumab for rituximab-induced SCLE and cryoglobulinemic vasculitis in primary Sjögren's disease: a case report.

Journal: Frontiers in pharmacology

Published: April 14, 2026

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 25, 2026

Mediterranean diet and health outcomes in idiopathic inflammatory myopathies.

Mediterranean diet and health outcomes in idiopathic inflammatory myopathies.

Journal: Rheumatology (Oxford, England)

Published: March 09, 2026

Interstitial lung disease in ANCA-associated vasculitis: comment on the article by Chalkia et al.

Interstitial lung disease in ANCA-associated vasculitis: comment on the article by Chalkia et al.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 27, 2026

Tocilizumab and Rituximab in Systemic Sclerosis: A Real-Life Retrospective Observational Study Across Different Clinical Phenotypes.

Tocilizumab and Rituximab in Systemic Sclerosis: A Real-Life Retrospective Observational Study Across Different Clinical Phenotypes.

Journal: Journal of personalized medicine

Published: February 16, 2026

Comment on: Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study: Reply.

Comment on: Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study: Reply.

Journal: Rheumatology (Oxford, England)

Published: January 28, 2026

Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group.

Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group.

Journal: RMD open

Published: September 24, 2025

Case report: atypical anti-SAE1 autoantibody manifestation with splinter hemorrhages as onset, and related to urothelial cancer.

Case report: atypical anti-SAE1 autoantibody manifestation with splinter hemorrhages as onset, and related to urothelial cancer.

Journal: European review for medical and pharmacological sciences

Published: September 04, 2025

Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension.

Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension.

Journal: Therapeutic advances in musculoskeletal disease

Published: July 30, 2025

Biorepositories For Global Rare Disease Research: A Narrative Review.

Biorepositories For Global Rare Disease Research: A Narrative Review.

Journal: Current rheumatology reports

Published: April 30, 2025

The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registry.

The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registry.

Journal: Seminars in arthritis and rheumatism

Published: April 02, 2025

Showing 1-12 of 24

Last Updated: 09/26/2026